|
HS Code |
826827 |
| Product Name | Scrophulariae Radix Veterinary Grade API |
| Dosage Forms | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Active Ingredient | Scrophulariae Radix (Root of Scrophularia ningpoensis) |
| Intended Use | Veterinary Medicine |
| Appearance | Brown to dark brown powder or extract |
| Purity | >=98% (varies by manufacturer specification) |
| Solubility | Partially soluble in water and ethanol |
| Storage Conditions | Store in cool, dry place; protect from light |
| Shelf Life | 2-3 years under proper storage conditions |
| Country Of Origin | China (major sourcing region) |
| Certification | GMP certified production (varies by supplier) |
| Package Options | 25kg fiber drum or customized packaging |
| Main Functions | Anti-inflammatory, antipyretic, immune modulation (animal health) |
| Standardization | According to Veterinary Pharmacopoeia standards |
| Lot Number | Provided on the certificate of analysis |
As an accredited Scrophulariae Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, airtight, tamper-evident HDPE drum with blue lid, labeled, containing 25 kg of Scrophulariae Radix Veterinary Grade API powder. |
| Shipping | Shipping for Scrophulariae Radix Veterinary Grade API is conducted in compliance with international regulations for pharmaceutical ingredients. The product is securely packed in sealed, tamper-proof containers to preserve quality during transit. Temperature and humidity controls are maintained as required. Standard documentation, including Material Safety Data Sheets (MSDS), is provided for each shipment. |
| Storage | Store Scrophulariae Radix Veterinary Grade API in a tightly sealed container, protected from light, moisture, and excessive heat. Maintain storage in a cool, dry, well-ventilated area at room temperature (15–25°C). Keep away from incompatible substances and out of reach of unauthorized personnel. Ensure appropriate labeling and comply with all regulatory storage requirements for pharmaceuticals and veterinary bulk drugs. |
|
Purity 98%: Scrophulariae Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with 98% purity is used in livestock anti-inflammatory treatments, where higher purity ensures optimal therapeutic outcomes. Particle Size D90<50μm: Scrophulariae Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with particle size D90<50μm is used in oral powder formulation, where fine particle distribution improves bioavailability and absorption rates. Moisture Content <5%: Scrophulariae Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with moisture content below 5% is used in injectable veterinary solutions, where low moisture prevents microbial growth and maintains product stability. Melting Point 210°C: Scrophulariae Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with melting point at 210°C is used in the manufacturing of heat-processed granules, where high thermal stability preserves API integrity. Stability Temperature up to 40°C: Scrophulariae Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with stability up to 40°C is used in premix feed additives, where enhanced stability ensures consistent potency during storage. Water Solubility >90%: Scrophulariae Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with water solubility over 90% is used in oral liquid solutions for veterinary dosing, where rapid dissolution facilitates accurate administration. Ash Content <1%: Scrophulariae Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with ash content less than 1% is used in capsule formulations, where low inorganic residue reduces risk of excipient interaction. Heavy Metals <10ppm: Scrophulariae Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with heavy metal levels below 10ppm is used in animal health supplements, where minimal contamination ensures safety compliance. Microbial Limits <1000cfu/g: Scrophulariae Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with microbial limits under 1000cfu/g is used in sterile veterinary injections, where strict microbial control guarantees product safety. |
Competitive Scrophulariae Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Scrophulariae Radix, known in many veterinary circles as an established botanical resource, has provided a reliable component in traditional animal healthcare for generations. Our factory specializes in delivering Scrophulariae Radix as a veterinary active pharmaceutical ingredient (API), prepared for versatile manufacturing needs including tablets, injections, capsules, powders, granules, premix, and solutions. By handling every step in the process on-site—from raw root selection, cleaning, and extraction through purification and final packaging—we stand by the traceability and consistency essential to veterinary pharmaceutical production.
In the plant’s receiving area, choosing the right batch of Scrophulariae Radix sets the tone for everything that follows. Quality checks start there. Roots arrive dried, and every lot undergoes a visual inspection to weed out material that doesn’t meet our long-standing physical standards. Technicians look for size, dryness, absence of contaminants, and characteristic fragrance—details that impact the outcome of every finished batch down the line.
Once raw material qualifies, our process runs through water extraction, low-temperature concentration, filtration, purification, and drying. These steps follow specifications developed through years of research and feedback from formulation teams. The chemistry of Scrophulariae Radix—the spectrum of iridoid glycosides, saponins, and other polyphenols—deserves careful handling, especially for applications in animal health where batch-to-batch variation can spell the difference between success and unforeseen outcome in the field.
Nothing tests a botanical API more than its performance under pressure—literally, in the case of tablet and capsule manufacture. To support direct compression, we pay extra attention to particle size and flow. After extraction and spray-drying, samples proceed through sieving, where they are measured and observed for stickiness, dusting, and agglomeration. Compressibility testing in real tableting lines runs parallel to QC sampling. Producing veterinary APIs in powder and granule formats brings added challenges, especially for large-scale feed premixes. Formulators need to achieve even distribution in every scoop, and our processing lines include thorough mixing and frequent in-process checks for homogeneity, moisture content, and solubility.
In injections and solutions, the focus turns from physical to chemical purity. The water extracted from Scrophulariae Radix comes filtered down to micron-grade and, for some uses, even finer. Critical steps include removal of insoluble particles—because no injectable should present visible residue—and repeated purification cycles to knock impurities below the required thresholds. Our QC team utilizes liquid chromatography for glycoside quantitation, while microbiological checks rule out contamination that would make the product unsuitable for parenteral use.
Demand from veterinary drug and supplement manufacturers has shaped the way we process Scrophulariae Radix. Our earliest batches met farm-level needs—simple powders for feed blends—yet over the years, demand accelerated for highly purified APIs capable of stable performance in finished dosage forms. Working with local feed mills, compounders, and animal drug manufacturers, we’ve adjusted drying times, granulation methods, and purity profiles. Our team monitors the stability of iridoid glycosides through freeze-thaw cycles and varying pH—a concern raised by injectable solution makers who reported that poor stability can quickly decrease product shelf life and therapeutic value.
Animal health innovators have asked for APIs that mix cleanly into carrier materials, dissolve without residue, and hold up during transport and storage. Adjustments in our process reflect these requests. For example, we tailor the drying temperature and humidity to keep the balance of actives intact, and buffer the extract at critical points so it remains suitable for heat-sensitive format production.
Many animal health suppliers buy Scrophulariae Radix from traders or bulk processors whose main focus lies in human supplement markets. These products sometimes appear similar on a data sheet, but our work on the manufacturing floor tells another story. Veterinary formulations require strict control not only of key actives but also of trace contaminants, residual solvents, and moisture content. Our granules and powders undergo process validation beyond what’s expected for traditional herbal medicine, ensuring that each lot falls within veterinary release criteria every time.
Users often mention color, odor, and powder handling as pain points. We manage sensory attributes tightly by adjusting processing methods to avoid burnt or overly earthy notes, striving for repeatable results in every container, so downstream users can manufacture without surprises—especially in blends for high-value animals where palatability can affect acceptance and compliance. Scrophulariae Radix sourced from commodity brokers often lacks this guarantee. Consistency in veterinary medicine means fewer formulation headaches, less rework, and reliability with every product launch.
Many competitors provide only coarse-cut root or loose powder. Our line delivers granules, microfine powders, and highly soluble extracts, with everything processed in-house in accordance with documented production protocols. The difference becomes apparent in yield and handling during high-speed blending, as well as in the clarity and stability of finished solutions for injectables and oral liquids. Our in-house validation extends to microbial safety, with heat and filtration steps customized to prevent spoilage—relevant for premixes destined for long storage or shipment to distant markets.
We understand the requirements of regulatory agencies overseeing animal healthcare products. From batch sampling by lot number, to confirmed COAs and full-traceability records, our efforts reflect best practices in pharmaceutical ingredient manufacturing. Throughout the year, our research group partners with animal science institutes to monitor trends in livestock and companion animal health. In response, we adapt both process and product specifications to the evolving context of veterinary needs.
Formulators looking to expand their OTA (over-the-counter animal) offerings asked for faster-dissolving, easy-to-flavor versions of Scrophulariae Radix to support high compliance in small-animal and equine supplements. Others, working on controlled-release technology for large-volume injectables, highlighted the need for a higher-purity extract with a narrower range of active proportions. On the production line, we tackled these issues through modified extraction protocols and precision granulation processes, using feedback loops from field studies and customer trials to tune every batch.
Our solutions for tablets and capsules reflect these challenges. Each batch undergoes additional friability and disintegration assessments, mimicking the harsh handling conditions of mixed feed or bulk tablet containers on farms. The goal is to minimize dust, reduce breakage, and preserve uniform content per dose. The team invests daily effort to maintain these standards, shaping the product for reliability in veterinary formulations.
With trust and compliance as top value drivers for veterinarians and producers, more manufacturers push for origin-verifiable, authentic Scrophulariae Radix in their APIs. Our procurement protocol excludes shortcuts. Raw root comes from fields monitored under our own agronomy program, ensuring correct plant species and harvest timing. DNA barcoding supports visual ID checks. Internally, each step—grinding, extraction, and packaging—carries a batch number, linking the API directly to its field origin. Regulators and third-party auditors point to traceability as a pillar of animal medicine safety, especially for feed and injectable applications. By managing all phases under one roof, we control more variables before the API reaches a client’s blending or tableting line.
Veterinary products sometimes take years to reach market. Formulators investing in new finished products want assurance that every ingredient will remain available, unchanged, for the lifecycle of the release. Our contract manufacturing agreements reflect this practical reality. Advance notice for any proposed process modification, locked-in specifications, and advance batch reserve options all help clients plan their supply with confidence. Repeated audits and documentation support applications in settings ranging from local animal hospitals to large integrated agricultural operations.
Direct discussion with tablet, premix, and solution compounders has shaped much of our approach. From the earliest phase of method development, we invite feedback—sometimes from small startups, at other times from leaders in multinational animal health. Batch samples run through client’s own handling tests, with all parties sharing results and proposing improvements. For example, if a formulation team observes unexpected sedimentation or discoloration in a liquid, we work together to redesign filtration or adjust drying to resolve the issue. The process is iterative and driven by practical use on the customer side rather than solely by internal metrics.
Our research does not end at production. Random stability checks and shelf simulations run throughout product lifecycle, and we dedicate a team to researching changes in active profile under real-world storage scenarios in shipping containers, feed barns, and veterinary clinics. Drawing on data from these studies, we keep our specification sheets and process records up-to-date—not to impress buyers with paperwork, but to prevent surprises for real users. These checks ensure that as veterinary medicine standards rise, our Scrophulariae Radix API keeps pace, protecting animal health and supporting better business for our partners.
Animal drug and feed supplement regulation is a highly specialized field, often requiring ingredients to meet stricter standards than those in equivalent human supplements. In practice, this means not only analyzing actives, but also controlling for pesticide residues, heavy metals, and unwanted microorganism loads. We implement targeted monitoring on every production run, focusing analytical resources on those points with real potential for contamination. For products shipping to overseas veterinary clients, extra documentation supports compliance with importing authority requirements.
On several occasions, partners have asked us to adapt Scrophulariae Radix for zero-antibiotic production chains. To support these needs, we certifiy raw sources as untreated by post-harvest fumigation or irradiation. The line resists cross-contamination through airlocks, and we periodically validate the cleaning cycle with each changeover. While human supplement processors may not always follow these controls, we see tangible benefits in animal welfare outcomes—in pilot work, reduction in palatability issues and improved acceptance rates for oral doses.
Veterinary practice environments pose unique handling challenges. Farm technicians or veterinary nurses may not have access to specialized powder blending or tableting equipment. For this reason, our team develops and tests the API to perform predictably under “real-life” handling—whether shaken into a water-based premix, tapped into capsules, or dispensed in field clinics with minimal support. Powders and granules reach their intended strength with simple hand mixing, preventing dose error even with limited resources.
Users report back on important details overlooked in most manufacturing literature: the way a powder pours, how much airborne dust results from mixing, whether granules clump in humid air, and if suspensions remain stable during repeated withdrawal from a dosing reservoir. In response, plant technicians revisit the process, making targeted adjustments to moisture reduction or flow-aid addition to support smoother use in veterinary and farm operations.
Ease of dosing in animals, especially when palatability or volume can affect compliance, drives continuous improvement. Research at our facility includes taste-masking trials and physical stability checks at varying temperatures, reflecting the real-life transportation and storage conditions found in veterinary practice.
Every lot shipped is just the beginning of a journey—tracking ongoing product performance in the field has shaped the way we approach API manufacturing for Scrophulariae Radix. We document feedback, whether from large-scale producers or small clinics, to gain direct insight into how our ingredients perform under the conditions that matter. This extends to post-market surveillance, where teams record compliance, incidence of adverse reactions, and performance benchmarks for multispecies dosing.
through network of veterinary science partners, we gather information about emerging disease threats, shifts in animal husbandry, and the evolving needs of veterinarians striving for better outcomes with botanical APIs. When a new pathogen or regulation prompts reformulation, our process proves agile enough to support fast turnaround and, if needed, new purification standards. The value of direct communication with users can’t be overstated; these insights not only improve our process, but ultimately help ensure better products on the shelf.
Scrophulariae Radix production begins in the field, where soil health, rainfall, and sustainable harvesting shape the future quality of the API. We partner with growers following documented sustainability plans, meeting annual foraging quotas to safeguard plant populations. Our organic waste stream—root residue, spent extraction solvent, and rinse water—feeds into a plant-wide recycling loop or feeds compost for the next generation of crops. Every season, agronomists review soil nutrient profiles and prevent over-harvesting by setting time-based rotation schedules for contracted plots.
In the extraction facility, water and energy conservation take priority. Automated controls limit water flow, and condensate recovery reduces resource waste. State-of-the-art filtration units recapture usable solvent, and a heat exchange system channels energy into rewarming processes elsewhere in the plant. By reducing the environmental burden of producing animal health APIs, we not only comply with evolving regulatory mandates but also support the long-term viability of both agriculture and animal care markets.
From selecting Scrophulariae Radix roots in the field to finished powder, granule, or liquid API, our team’s choices affect veterinarians, producers, and ultimately, animal welfare itself. Sound process control, open feedback channels with users, and a commitment to traceability ensure every kilogram is made for veterinary health, not just for generic bulk supplement supply. We’re proud to support new advances in animal care, and we look forward to further collaboration with the veterinary sciences community to shape the future of botanical APIs for tablets, injections, capsules, powders, granules, premix, and solutions.